Key opinion leader discusses the exciting FDA approval of the subcutaneous formulation of daratumumab for the treatment of multiple myeloma.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!
Key opinion leader discusses the exciting FDA approval of the subcutaneous formulation of daratumumab for the treatment of multiple myeloma.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]